Healthcare provider profile · identity verified

Phillip E Tobash, D.O.

Family Practice · SCHUYLKILL HAVEN, PA · NPI 1659344455

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	114
Metoprolol Succinate	Metoprolol Succinate	436	102
Amlodipine Besylate	Amlodipine Besylate	419	89
Lisinopril	Lisinopril	400	92
Levothyroxine Sodium	Levothyroxine Sodium	268	61
Omeprazole	Omeprazole	251	57
Pantoprazole Sodium	Pantoprazole Sodium	201	52
Metformin Hcl Er	Metformin Hcl	190	41
Losartan Potassium	Losartan Potassium	182	35
Eliquis	Apixaban	181	30
Lorazepam	Lorazepam	173	31
Clopidogrel	Clopidogrel Bisulfate	171	32
Furosemide	Furosemide	170	36
Tramadol Hcl	Tramadol Hcl	145	27
Tamsulosin Hcl	Tamsulosin Hcl	135	31
Metoprolol Tartrate	Metoprolol Tartrate	127	33
Escitalopram Oxalate	Escitalopram Oxalate	123	27
Simvastatin	Simvastatin	123	30
Meloxicam	Meloxicam	122	33
Gabapentin	Gabapentin	121	32
Albuterol Sulfate Hfa	Albuterol Sulfate	120	34
Allopurinol	Allopurinol	111	26
Trazodone Hcl	Trazodone Hcl	107	20
Prednisone	Prednisone	103	59
Duloxetine Hcl	Duloxetine Hcl	101	14
Metformin Hcl	Metformin Hcl	101	22
Potassium Chloride	Potassium Chloride	97	11
Rosuvastatin Calcium	Rosuvastatin Calcium	90	27
Jardiance	Empagliflozin	88	18
Glipizide Er	Glipizide	85	21
Sertraline Hcl	Sertraline Hcl	84	21
Buspirone Hcl	Buspirone Hcl	69	15
Pravastatin Sodium	Pravastatin Sodium	66	20
Alprazolam	Alprazolam	60	15
Azithromycin	Azithromycin	60	52
Montelukast Sodium	Montelukast Sodium	60	14
Donepezil Hcl	Donepezil Hcl	59	suppressed
Labetalol Hcl	Labetalol Hcl	59	11
Bisoprolol Fumarate	Bisoprolol Fumarate	58	suppressed
Celecoxib	Celecoxib	54	16
Irbesartan	Irbesartan	54	13
Memantine Hcl	Memantine Hcl	54	suppressed
Famotidine	Famotidine	52	13
Tizanidine Hcl	Tizanidine Hcl	52	20
Clonazepam	Clonazepam	51	suppressed
Synthroid	Levothyroxine Sodium	50	11
Hydrochlorothiazide	Hydrochlorothiazide	48	17
Ramipril	Ramipril	47	suppressed
Carvedilol	Carvedilol	46	13
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Meclizine Hcl	Meclizine Hcl	40	15
Benazepril Hcl	Benazepril Hcl	39	suppressed
Ozempic	Semaglutide	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Valsartan	Valsartan	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	suppressed
Finasteride	Finasteride	35	suppressed
Olanzapine	Olanzapine	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	23
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Cefuroxime	Cefuroxime Axetil	27	23
Januvia	Sitagliptin Phosphate	26	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Ezetimibe	Ezetimibe	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	suppressed
Topiramate	Topiramate	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	13
Ibuprofen	Ibuprofen	21	suppressed
Levofloxacin	Levofloxacin	21	15
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	13
Nifedipine Er	Nifedipine	19	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	19	14
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	15
Torsemide	Torsemide	18	suppressed
Ketoconazole	Ketoconazole	17	12
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Baclofen	Baclofen	15	suppressed
Cephalexin	Cephalexin	15	14
Cilostazol	Cilostazol	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nitroglycerin	Nitroglycerin	15	12
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diazepam	Diazepam	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error